The Potential of mHealth as a Game Changer for the Management of Sickle Cell Disease in India

Sickle cell disease (SCD) is a chronic genetic disease that requires lifelong therapy and monitoring. Low drug adherence and poor monitoring may lead to an increase in morbidities and low quality of life. In the era of digital technology, various mobile health (mHealth) apps are being tested for their potential in increasing drug adherence in patients with SCD. We herewith discuss the applicability and feasibility of these mHealth apps for the management of SCD in India.

Automated summary

Sickle cell disease is a chronic genetic disease that requires lifelong therapy and monitoring. Mobile health apps are being tested for their potential in increasing drug adherence in patients with SCD. In the Indian context, these mHealth apps may have applicability and feasibility for the management of SCD.